Publication | Closed Access

Baroreflex Activation Therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial

Non-pharmacological InterventionHypertensionHeart FailureDurable BenefitCardiovascular DiseaseMedicineAntihypertensive TherapyRheos Pivotal TrialBlood Pressure ControlPharmacotherapyBaroreflex Activation TherapyPharmacologyBlood PressureEndocrine Hypertension